Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | GSK3A | P49840 | 2/20 | 0.37 |
| ▸ | GSK3B | P49841 | 2/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 2/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15281062 | 0.89 | ALDH1A1 (0.39) | ALDH1A1PKMGSK3AGSK3BMGLL | |
| SCHEMBL6850987 | 0.79 | GSK3A (0.44) | ALDH1A1GSK3AGSK3BMGLLCASP3 | |
| SCHEMBL4848548 | 0.78 | CASP3 (0.31) | ALDH1A1CASP3 | |
| SCHEMBL13252216 | 0.78 | ALDH1A1 (0.33) | ALDH1A1PKM | |
| SCHEMBL13878863 | 0.78 | DUSP3 (0.35) | ALDH1A1PKMCASP3MAPT | |
| SCHEMBL19059392 | 0.78 | BCL2A1 (0.32) | ALDH1A1CASP3MAPT | |
| SCHEMBL19721765 | 0.78 | MEN1 (0.31) | CASP3PTGS2MEN1KMT2A | |
| SCHEMBL10119694 | 0.74 | ALDH1A1 (0.31) | ALDH1A1PKM | |
| SCHEMBL19506224 | 0.74 | GSK3A (0.35) | ALDH1A1GSK3AGSK3BMGLLCASP3 | |
| SCHEMBL19506068 | 0.74 | GSK3A (0.35) | ALDH1A1GSK3AGSK3BMGLLCASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 533 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3551675-A1 | RESIN COMPOSITIONS | Novoset, LLC (US) | 2019-10-16 | — | — | EP | claimed |
| WO-2018111337-A1 | RESIN COMPOSITIONS | NOVOSET, LLC (US) | 2018-06-21 | — | — | WO | claimed |
| US-12043781-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-20240067879-A1 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-02-29 | — | — | US | disclosed |
| US-11873439-B2 | Polymerisable liquid crystal material and polymerised liquid crystal film | MERCK PATENT GMBH (DE) | 2024-01-16 | — | — | US | disclosed |
| US-11873438-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-01-16 | — | — | US | disclosed |
| US-11834598-B2 | Dielectric copolymer materials | MERCK PATENT GMBH (DE) | 2023-12-05 | — | — | US | disclosed |
| US-11834598-B2 | Dielectric copolymer materials | MERCK PATENT GMBH (DE) | 2023-12-05 | — | — | US | disclosed |
| US-11820932-B2 | Polymerisable liquid crystal material and polymerised liquid crystal film | MERCK PATENT GMBH (DE) | 2023-11-21 | — | — | US | disclosed |
| US-20230357637-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-09 | — | — | US | disclosed |
| US-11802243-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2023-10-31 | — | — | US | disclosed |
| EP-1666461-A2 | Polyaspartimides useful as reactive components for polyisocyanates in two-component polyurethane coating compositions | Bayer MaterialScience AG (DE) | 2006-06-07 | — | — | EP | disclosed |
| US-20060106194-A1 | Polyaspartimides | BAYER MATERIALSCIENCE LLC | 2006-05-18 | — | — | US | disclosed |
| WO-2005073188-A1 | ASPARTATES USEFUL AS COMPONENTS IN COATING COMPOSITIONS AND THEIR PREPARATION | BAYER MATERIALSCIENCE LLC (US) | 2005-08-11 | — | — | WO | disclosed |
| US-20050159560-A1 | PROCESS FOR PREPARING ASPARTATES | COVESTRO DEUTSCHLAND AG (DE) | 2005-07-21 | — | — | US | disclosed |
| US-6911501-B1 | Reacting a di- or polyamine with an unsaturated ester and then reacting the resultant product with a maleimide, useful as reactive component for polyisocyanates in two-component polyurethane coating formulation | BAYER MATERIALSCIENCE LLC (US) | 2005-06-28 | — | — | US | disclosed |
| US-20040260137-A1 | Process for the removal of conjugated olefins from a monoolefin stream | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2004-12-23 | — | — | US | disclosed |
| CN-1541529-A | Sustained releasing agent for preventing and treating alga and legionella bacteria series and its compositions | 益博爱股份有限公司 | 2004-11-03 | — | — | CN | disclosed |
| US-6720468-B2 | BY REACTING WITH A DIELS-ALDER DIENOPHILE TO PROVIDE A FLUID COMPRISING A DIELS-ALDER ADDUCT AND MONOOLEFINS; AND RECOVERING A RESULTING MONOOLEFIN-CONTAINING FLUID | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2004-04-13 | — | — | US | disclosed |
| US-20020165420-A1 | Process for the removal of conjugated olefins from a monoolefin stream | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2002-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040260137-A1 | Process for the removal of conjugated olefins from a monoolefin stream | AKR7A2, DERA, APEX1 | ALDH1A1 142/4885PKM 2261/4885GSK3A 4106/4885 |
| US-20020165420-A1 | Process for the removal of conjugated olefins from a monoolefin stream | ADH1C, ADH1A, OXER1 | ALDH1A1 58/4885PKM 3159/4885GSK3A 3451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.